托吡酯结构式
|
常用名 | 托吡酯 | 英文名 | Topiramate |
---|---|---|---|---|
CAS号 | 97240-79-4 | 分子量 | 339.362 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 438.7±55.0 °C at 760 mmHg | |
分子式 | C12H21NO8S | 熔点 | 125ºC | |
MSDS | 中文版 美版 | 闪点 | 219.1±31.5 °C | |
符号 |
GHS02, GHS06, GHS08 |
信号词 | Danger |
托吡酯用途Topiramate是镇痉化合物,能拮抗GluR5受体,还可作为GABA受体介导的电流阳性变构调节剂。 |
中文名 | 托吡酯 |
---|---|
英文名 | topiramate |
中文别名 | 2,3:4,5-双-0-(1-甲基亚乙基)-Β-吡喃果糖氨基磺酸酯 | 2,3,4,5-双-O-(1-甲基亚乙基)-Β-D-吡喃果糖氨基磺酸酯 | 托佩马特 | 2,3,4,5-双-o-(1-甲基亚乙基)-β-d-吡喃果糖氨基磺酸酯 | 妥泰,2,3:4,5-双-0-(1-甲基亚乙基)-β-吡喃果糖氨基磺酸酯 | 妥吡酯 |
英文别名 | 更多 |
描述 | Topiramate是镇痉化合物,能拮抗GluR5受体,还可作为GABA受体介导的电流阳性变构调节剂。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 438.7±55.0 °C at 760 mmHg |
熔点 | 125ºC |
分子式 | C12H21NO8S |
分子量 | 339.362 |
闪点 | 219.1±31.5 °C |
精确质量 | 339.098785 |
PSA | 123.92000 |
LogP | 2.97 |
外观性状 | 白色至灰白色结晶粉末 |
蒸汽压 | 0.0±1.1 mmHg at 25°C |
折射率 | 1.497 |
储存条件 | 0-10°C;避免加热 |
水溶解性 | 可溶于:甲醇 |
符号 |
GHS02, GHS06, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H225-H301 + H311 + H331-H370 |
警示性声明 | P210-P260-P280-P301 + P310-P311 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | 26-36 |
危险品运输编码 | UN1230 - class 3 - PG 2 - Methanol, solution |
WGK德国 | 3 |
RTECS号 | LS7083000 |
~80% 托吡酯 97240-79-4 |
文献:EP1627881 A1, ; Page/Page column 3 ; |
~76% 托吡酯 97240-79-4 |
文献:WO2007/99388 A1, ; Page/Page column 6 ; |
~% 托吡酯 97240-79-4 |
文献:WO2004/89965 A2, ; Page title page; 9-10 ; |
~61% 托吡酯 97240-79-4 |
文献:US2006/40874 A1, ; Page/Page column 6-7 ; |
~% 托吡酯 97240-79-4 |
文献:WO2003/97656 A2, ; Page/Page column 101; 102 ; |
~29% 托吡酯 97240-79-4 |
文献:Journal of Medicinal Chemistry, , vol. 41, # 8 p. 1315 - 1343 |
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Nature 457(7231) , 910-4, (2009) Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the i... |
|
Kainic Acid-Induced Golgi Complex Fragmentation/Dispersal Shifts the Proteolysis of Reelin in Primary Rat Neuronal Cells: An In Vitro Model of Early Stage Epilepsy.
Mol. Neurobiol. , (2015) The endoplasmic reticulum-lysosome-Golgi network plays an important role in Reelin glycosylation and its proteolytic processing. Golgi complex fragmentation is associated with the separation of Reelin... |
|
Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
JAMA 311(18) , 1889-900, (2014) Alcohol use disorders cause substantial morbidity and early mortality yet remain greatly undertreated. Medications are considerably underused.To conduct a systematic review and meta-analysis of the be... |
Topamax Sprinkle |
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate |
Topiramate |
Topimax |
Tipiramato [Spanish] |
Epitomax |
McN-4853 |
topiramatum [Latin] |
topiramatum |
Tipiramate [French] |
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate |
Tipiramate |
[(3aS,5aR,8aR,8bS)-2,2,7,7-Tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate |
RWJ 17021-000 |
Topamax |
Topomax |
Topiramato [INN-Spanish] |